IGMS NASDAQ
IGM Biosciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +10.4%
1Y: -85.7%
3Y: -95.1%
5Y: -97.7%
$1.27
Last traded 2025-08-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$145M
Revenue
+4882.8% YoY
$-53M
Net Income
+75.8% YoY
$-159M
Free Cash Flow
+9.9% YoY
99.7%
Gross Margin
90.7%
Op. Margin
67.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-47.8%
ROA-24.1%
ROIC651.8%
Valuation
P/E-0.4
P/B1.6
EV/EBITDA1.1
Leverage
Debt/Equity0.00
Current Ratio17.66
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z-4.58
Beneish M101.41